key: cord-0894634-h21kuyfa
authors: Sohrab, Sayed Sartaj; El-Kafrawy, Sherif Aly; Mirza, Zeenat; Hassan, Ahmed M.; Alsaqaf, Fatima; Azhar, Esam Ibraheem
title: Designing and evaluation of MERS-CoV siRNAs in HEK-293 Cell line
date: 2020-12-29
journal: J Infect Public Health
DOI: 10.1016/j.jiph.2020.12.018
sha: d755b9119df2e6d152af3381969072cd601f2abc
doc_id: 894634
cord_uid: h21kuyfa

BACKGROUND: The MERS-CoV was identified for the first time from Jeddah, Saudi Arabia in 2012 from a hospitalized patient. This virus has now been spread to 27 countries with a total of 858 deaths and 2,494 confirmed cases and has become a serious concern for the human population. Camels are well known for the transmission of the virus to the human population. METHODS: In this report, we have discussed the designing, prediction, and evaluation of potential siRNAs against the orf1ab gene of MERS-CoV. The online software was used to predict and design the siRNAs and finally, total twenty-one siRNA were filtered out from four hundred and sixty-two sIRNAs as per their scoring and specificity criteria. We have used only ten siRNAs to evaluate their cytotoxicity and efficacy by reverse transfection approach in HEK-293-T cell lines. RESULTS: Based on the results and data generated; no cytotoxicity was observed for any siRNAs at various concentrations in HEK-293-T cells. The ct value of real-time PCR showed the inhibition of viral replication in siRNA-1, 2, 4, 6, and 9. The data generated provided the preliminary information and encouraged us to evaluate the remaining siRNAs separately as well as in combination to analyses the replication of MERS-CoV inhibition in other cell lines. CONCLUSION: Based on the results obtained; it is concluded that the prediction of siRNAs using online software resulted in the filtration of potential siRNAs with high accuracy and strength. This technology can be used to design and develop antiviral therapy not only for MERS-CoV but also against other viruses.

countries with a total of 858 deaths and 2,494 confirmed cases [2] . The camels are well reported for source virus transmission and infection to the human population [3] [4] [5] [6] [7] [8] . The MERS-CoV-infected individuals develop a cluster of symptoms like fever, shortness of breath, and multi-organ failure in critically ill patients [9] . The MERS-CoV belongs to the family Coronaviridae and known as a large group of viruses infecting humans and animals continuously. Based on the genetic diversity and host range; coronaviruses have been divided into four main groups and designated as Alpha, Beta, Gamma, and Delta coronaviruses. The genome of Coronaviruses varies from 25.0-32.0 kb and is observed to have high genetic diversity which favors the high rate of recombination and emergence of new viral strains with novel characteristics and extended host range [10] .

The regulatory role of RNA interference (RNAi) using short interfering RNAs (siRNAs), micro RNA (miRNAs) as significant antiviral therapy has been observed against many viral and deadly diseases. The RNAi is a valuable biological process to control the specific gene expression in eukaryotes by downregulating, silencing, and degrading the mRNAs of a specific gene [11] [12] . The siRNAs are short sequences of RNA ranged from 21 to 23 base pairs associated with 5' phosphate group and a 3' hydroxyl group. These siRNAs bind to a specific protein and forms a complex known as RNA Induced Silencing Complex (RISC), which further binds to specific RNA sequences and finally degrades the RNA resulting in the silencing of mRNA expression [13] . Based on the current status of published information; the potential siRNAs have been used to evaluate the significant inhibition of viral replication in many cell lines against multiple viruses including HIV [14] , Flock house virus (FHV) [15] , Rous sarcoma virus [16] , Dengue virus [17] , Hepatitis C virus (HCV) [18] , Influenza virus [19, 20] , Hepatitis B virus (HBV) [20, 21] , Human Papillomavirus (HPV) [22] and recently for SARS coronavirus (SARS-CoV) [23] .

The In-silico prediction and designing of siRNAs by using the computational biology approach provides the filtering of potential siRNAs candidates with high target specificity and reduced off-target effects. The basic rules and guidelines for siRNAs designing have been published in many reports. For designing of potential siRNAs, the basic criteria and other critical issues should be considered such as conserved genome sequences, off-target effects, siRNA folding, thermodynamic properties, target accessibility, stability, and immuno-stimulation of siRNAs [24] [25] [26] . In a recent study conducted using Vero cells, cytopathic effect was specifically inhibited resulting in less virus titer by siRNA targeting viral RNA polymerases of SARS-CoV [27] . Additionally, the function of the SARS-CoV-Spike protein gene was selectively silenced by DNA vector-driven siRNA in SARS-infected 293T cells. Another study showed that SARS-CoV infection and replication in fetal rhesus kidney cells was inhibited by siRNA duplexes J o u r n a l P r e -p r o o f targeting viral RNA polymerases, and spike protein gene. Currently, miRNA and siRNA-based candidate drugs are being evaluated in more than 20 clinical trials. Therapeutic siRNAs and miRNAs are found to be the most promising biopharmaceuticals in commercial space as oligonucleotide-based next-generation medicines [28] . Recently, we have elaborately reviewed the design and delivery of potential siRNAs for MERS-CoV [26] . For In silico designing and prediction of siRNAs against MERS-CoV, currently, two studies have reported using orf1ab replicase polyprotein [29, 30] . The siRNAs were designed by using the integrative siRNA design including multiple bioinformatics tools and against the conserved regions (orf1ab) of the MERS-CoV genome. In this study, the in silico prediction, chemical synthesis, cytotoxic effect and antiviral activity of potential siRNAs against the MERS-CoV orf1ab region have been discussed. The designed siRNAs were synthesized commercially, and their cytotoxicity and efficacy have been validated using various dose-dependent experiments in HEK-293-T cells. The cells were transfected with selected siRNAs at various concentration and viral RNA was purified to determine the replication of virus inhibition by using real-time PCR assay. Based on the results generated from this work, we found that some siRNAs showed significant and potential antiviral activity and inhibited MERS-CoV replication at a low concentration (0.1nM-50nM) in HEK293-T cell lines.

To predict and design the potential siRNAs, we isolated full-genome of MERS-CoV and performed multiple sequence alignment using BioEdit software. Based on the sequence identity, the MERS-CoV-orf1ab gene was selected as the target and the overall steps of siRNA designing and filtration have been presented in figure 1. We have used the online software as an integrated bioinformatics approach to predict, design, and filtration of potential siRNAs [31] .

Based on the i-SCORE approach, a total of ten different siRNAs were selected by algorithm scores [32] [33] [34] [35] . To filter the potential siRNAs, we used the consensus multi-score threshold filtration layer by defining threshold accepted scores. Based on the integrated bioinformatics approach and strict selection criteria with different scoring tools; finally, we selected the ten most probable potential siRNAs with the desired characteristics [29] [30] [31] . The detailed information about the selected siRNAs has been presented in table 1. 

To avoid any off-target binding of the designed siRNAs; we have used two different phases of selection. In the first phase of screening, we find out the near complimentary and similarity match with human mRNA sequences in PubMed by using the BLAST and Smith-Waterman algorithms as implemented in ParAlign and increase the validity percentage of the siRNAs and excluded those siRNAs with the most off-target effects. In the second phase of screening, we excluded the siRNAs which showed any seed-region similarity with human mRNA [36] .

The predicted, designed, filtered and probable potential siRNAs were selected based on the strict rules and parameters described in the integrated bioinformatics approach [24, [34] [35] . The selected siRNAs were chemically synthesized by Integrated DNA Technologies (IDT-USA) and used for further cytotoxicity and validation study.

The 

To evaluate the cytotoxic effect of siRNAs on HEK 293-T cells; we used MTT assay commercial kit as per instruction (Invitrogen). The old DMEM media was changed with fresh media to the cells following the addition of 12 mM-MTT (10 l) and further incubated for 4 hours at 37°C. The formazan crystals were thoroughly dissolved by adding 100 L SDS-HCL solution following the further incubation for 4 hours at 37°C. After thoroughly mixing the cells; the absorbance was measured at 570 nm using SpectraMax i3x imaging cytometer and the mean OD value was used for cytotoxicity calculation using the standard formula.

We have used the previously standardized and published protocol for virus inoculation to the siRNAs transfected HEK 293-T cells (1 x10 4 ) [8] .The virus inoculation was performed after the siRNA transfection and cells were further grown and the cytopathic effect in HEK 293-T cells was observed daily for 3 days. After the full cytopathic effect, the cell supernatants and lysate were isolated for viral RNA isolation using QIAampViral RNA Mini Kit (Qiagen).

The purified RNA was further used for real-time RT-PCR [8] .

The viral RNA was purified from the cell supernatant and cell lysate by using the QIAamp Viral RNA Mini Kit (Qiagen), as per manufacturer's instructions. Finally, the real-time RT-PCR was performed by using the purified RNA for detection and quantification of virus inhibition using specific MERS-CoV open reading frame region orf1a and orf1b primers as described earlier [8] .

The whole-genome sequence of MERS-CoV was isolated and used to perform multiple sequence alignment and based on the alignment result, the orf1ab region was selected as target to design the siRNAs. The multiple sequence alignment results of the full-genome showed high similarity with all the analysed sequences of MERS-CoV. The online software was used for In silico designing and scoring of potential siRNAs targeting the targeted orf1ab gene of the MERS-CoV. By using the In silico prediction and selection criteria, the software generated many siRNAs to fulfil the criteria, but we selected only ten siRNAs based on the stringent filtration and screening strategy with functional, off-targets reduced siRNA. The predicted siRNAs were further evaluated for their cytotoxicity and inhibition of virus replication in the selected cell lines [24, [34] [35] .

The cytotoxicity of selected siRNAs was evaluated by applying the reverse transfection method using 

The against many viral diseases [37] . This technology is being used to significantly silence the expression of the desired gene against many diseases [28] . Currently, various types of siRNAs have been evaluated against HCV 5'-NTR, and found that HCV321, HCV353, HCV258 siRNA were the best and promising siRNAs for the inhibition of HCV replication. The MERS-S protein is responsible for the cell attachment and the replication of the virus is initiated by the binding of virus particles with cellular receptors. The orf1ab region includes two-thirds of the Coronavirus genome and encodes non-structural proteins [31] .The proper use of RNAi technology was hampered due to many obstacles like; off-target binding, delivery, stability, and stimulation of immune responses. But due to continuous research effort, most of the obstacles have been successfully overcome and many siRNAs based therapeutics have reached to an advanced stage of clinical trials against multiple diseases [31, [38] [39] [40] [41] [42] [43] .

In this study, we have predicted, designed, and evaluated the potential siRNAs in the HEK293-T cell line targeting the orf1ab gene of MERS-CoV using automated online software by filtering and excluding the off-target effects and considering various factors and stringent rules [24, [34] [35] .The evaluated siRNAs were observed to be highly effective to inhibit MERS-CoV replication. As a preliminary test for the proof of concept, our primary objective was to predict and design the potential siRNAs against the orf1ab gene as a target region of MERS-CoV. The secondary objective was to evaluate the cytotoxicity study and experimentally evaluate the efficacy of predicted siRNAs into HEK 293-T cells by real-time PCR. Based on the extensive bioinformatics analysis, the outputs resulted in many potential siRNAs against the target orf1ab gene of MERS-CoV, but we selected only ten siRNAs with improved target accessibility and expected high antiviral potency with no off-target effect. The predicted siRNAs were

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

Middle East respiratory syndrome coronavirus (MERS-CoV) Monthly Summary

Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans

Prevalence of MERS-CoV nasal carriage and compliance with the Saudi health recommendations among pilgrims attending the

Community case clusters of Middle East respiratory syndrome coronavirus in Hafr Al-Batin, Kingdom of Saudi Arabia: a descriptive genomic study

MERS-CoV outbreak in Jeddah--a link to health care facilities

Probable transmission chains of Middle East respiratory syndrome coronavirus and the multiple generations of secondary infection in South Korea

Evidence for camel-to-human transmission of MERS coronavirus

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

Middle East respiratory syndrome coronavirus (MERS-CoV): animal to human interaction

Criteria for effective design, construction, and gene knockdown by shRNA vectors

The role of RNAi and microRNAs in animal virus replication and antiviral immunity

Advances in mechanism of small RNAs

Efficacy Analysis of Combinatorial siRNAs against HIV Derived from One Double Hairpin RNA Precursor

Engineered Flock House Virus for Targeted Gene Suppression Through RNAi in Fruit Flies (Drosophila melanogaster) in Vitro and in Vivo

Structural and functional analysis of the Rous Sarcoma virus negative regulator of splicing and demonstration of its activation by the 9G8 SR protein

RNAi: antiviral therapy against dengue virus

In vitro inhibitory analysis of consensus siRNAs against NS3 gene of hepatitis C virus 1a genotype

Influenza A virus-derived siRNAs increase in the absence of NS1 yet fail to inhibit virus replication

In vivo inhibition of influenza A virus replication by RNA interference targeting the PB2 subunit via intratracheal delivery

Recent developments in antivirals against hepatitis B virus

Effects of siRNA-mediated suppression of HPV-11 L1

Anti-SARS coronavirus agents: a patent review (2008 -present)

MysiRNA-designer: a workflow for efficient siRNA design

Precise and efficient siRNA design: a key point in competent gene silencing. Cancer gene therapy

Design and Delivery of Therapeutic siRNAs: Application to MERS-Coronavirus

Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells

Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine. Molecular therapy

Design of Potential RNAi (miRNA and siRNA) Molecules for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Gene Silencing by Computational Method. Interdisciplinary sciences, computational life sciences

A Computational Approach for Predicting Role of Human MicroRNAs in MERS-CoV Genome

In Silico Design and Experimental Validation of siRNAs Targeting Conserved Regions of Multiple Hepatitis C Virus Genotypes

Rational siRNA design for RNA interference

An algorithm for selection of functional siRNA sequences

Ui-Tei K. siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect

siRNA Design Software for a Target Gene-Specific RNA Interference

Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing

RNAi in the regulation of mammalian viral infections

Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence

Role of RNA interference (RNAi) in dengue virus replication and identification of NS4B as an RNAi suppressor

Evaluation of canonical siRNA and Dicer substrate RNA for inhibition of hepatitis C virus genome replication--a comparative study

Inhibition of Hepatitis C Virus in Mice by a Small Interfering RNA Targeting a Highly Conserved Sequence in Viral IRES Pseudoknot

A novel cell-based assay to measure activity of Venezuelan equine encephalitis virus nsP2 protease

Role of viruses, prions and miRNA in neurodegenerative disorders and dementia. VirusDis